Host Transcriptional Response to Ebola Virus Infection.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 30, doi. 10.3390/vaccines5030030
- By:
- Publication type:
- Article
Works matching IS 2076393X AND DT 2017 AND VI 5 AND IP 3
Results: 15
1
2
Current Status of Rift Valley Fever Vaccine Development.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 29, doi. 10.3390/vaccines5030029
- By:
- Publication type:
- Article
3
Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 28, doi. 10.3390/vaccines5030028
- By:
- Publication type:
- Article
4
Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 27, doi. 10.3390/vaccines5030027
- By:
- Publication type:
- Article
5
An Atypical Local Vesicular Reaction to the Yellow Fever Vaccine.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 26, doi. 10.3390/vaccines5030026
- By:
- Publication type:
- Article
6
A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 25, doi. 10.3390/vaccines5030025
- By:
- Publication type:
- Article
7
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 24, doi. 10.3390/vaccines5030024
- By:
- Publication type:
- Article
8
The TRIMendous Role of TRIMs in Virus-Host Interactions.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 23, doi. 10.3390/vaccines5030023
- By:
- Publication type:
- Article
9
Challenges in Estimating Vaccine Coverage in Refugee and Displaced Populations: Results From Household Surveys in Jordan and Lebanon.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 22, doi. 10.3390/vaccines5030022
- By:
- Publication type:
- Article
10
Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 21, doi. 10.3390/vaccines5030021
- By:
- Publication type:
- Article
11
Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 20, doi. 10.3390/vaccines5030020
- By:
- Publication type:
- Article
12
Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 19, doi. 10.3390/vaccines5030019
- By:
- Publication type:
- Article
13
Egg-Independent Influenza Vaccines and Vaccine Candidates.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 18, doi. 10.3390/vaccines5030018
- By:
- Publication type:
- Article
14
Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 17, doi. 10.3390/vaccines5030017
- By:
- Publication type:
- Article
15
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection.
- Published in:
- Vaccines, 2017, v. 5, n. 3, p. 16, doi. 10.3390/vaccines5030016
- By:
- Publication type:
- Article